A new study from researchers at Sanford Burnham Prebys and Eli Lilly and Company describes the science behind an autoimmune disease treatment in a Phase 2 clinical trial.
Many in the county are facing barriers to adopting solar energy, but Sanford Burnham Prebys is leading the charge with a $2.5 million investment in solar power.
A new educational program at Sanford Burnham Prebys has welcomed a diverse group of early-career scientists to learn how to transform research discoveries into treatments for human diseases.